Skip to main content
. 2021 Mar 26;4(3):710–718. doi: 10.20517/cdr.2020.109

Table 2.

Expression of B-cells markers in tumor cell surfaces (CD20, CD79a, CD10, CD19) in the CD20 negative patients with relapsed or refractory follicular lymphoma at resample time on fresh tumor biopsy. All tests were performed by immunohistochemistry

CD20 CD79a CD10 CD19
Pt #15 - + + NA*
Pt #22 - + + +
Pt #24 - + + +
Pt #26 - NA* + NA*
Pt #28 - + + +

*The tumor material was sold out and not sufficient to perform these analyses. NA: Not available.